https://www.fool.com/investing/2022/07/29/why-invitae-health-stock-plummeted-this-week/
An analyst downgrades his recommendation on the stock, making a brutal cut to his price target while doing so.
motley foolinvitaehealthstockweek
https://www.prnewswire.com/news-releases/invitae-to-present-at-the-37th-annual-jp-morgan-healthcare-conference-300769905.html
/PRNewswire/ -- Invitae Corporation (NYSE: NVTA), one of the fastest growing genetics companies, today announced that Sean George, co-founder and chief...
j p morganinvitaepresentannual
https://www.entrepreneur.com/business-news/is-invitae-stock-a-buy-under-5/426762
Invitae's (NVTA) significant revenue growth in its most recently reported quarter and its success in bringing customized health monitoring into the mainstream...
invitaestockbuy
https://www.fool.com/investing/2024/01/29/is-invitae-stock-a-buy-now/?source=financialcontent&utm_source=financialcontent&utm_medium=feed&utm_campaign=article
Invitae shares have lost more than 80% over the past year and a half.
motley foolinvitaestockbuy